Skip to content

Clinical trials

Muscular Dystrophy, Duchenne trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Country / region: Japan Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20102
20111
20133
20142
20151
20162
20172
20191
20203
20213
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting6
Terminated4
Unknown status3
Enrolling by invitation1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NS Pharma, Inc.3
Pfizer3
Sarepta Therapeutics, Inc.3
Taiho Pharmaceutical Co., Ltd.3
Daiichi Sankyo Co., Ltd.2
GlaxoSmithKline2
National Center of Neurology and Psychiatry, Japan2
BioMarin Pharmaceutical1
Cooperative International Neuromuscular Research Group1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne26
Muscular Dystrophies6
Cardiomyopathies1
Genetic Diseases, Inborn1
Genetic Diseases, X-Linked1
Muscular Diseases1
Muscular Disorders, Atrophic1
Muscular Dystrophies, Limb-Girdle1
Musculoskeletal Diseases1
Nervous System Diseases1

Trials

Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.